Anonymous ID: 24979d Oct. 25, 2021, 7:36 a.m. No.14854081   🗄️.is 🔗kun   >>4086 >>4172

Connecting dots, eh.

 

https://www.newsday.com/news/health/coronavirus/pfizer-covid-vaccine-children-latest-news-1.50399574

 

https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-blood-thinning-medication-children

 

FDA Approves First Oral Blood Thinning Medication for Children

 

For Immediate Release:

June 21, 2021

 

The FDA granted the approval of Pradaxa to Boehringer Ingelheim Pharmaceuticals, Inc.

 

https://www.boehringer-ingelheim.com/covid-19/fighting-covid-19/global-access-commitment-with-gates-foundation

 

Boehringer Ingelheim has signed a communiqué jointly with the Bill & Melinda Gates Foundation and fifteen other pharmaceutical companies committing to providing global access to COVID-19 vaccines, diagnostics and therapeutics. The communiqué was presented by Bill Gates during an event at the United Nations General Assembly. It is sharing the commitment of Boehringer Ingelheim and the other pharmaceutical companies to end the pandemic as well as appealing to partners across the entire development-to-deployment pathway to become involved. Innovative research will only end the pandemic when paired with expansive collaboration among the life science companies as well as governments, NGOs, multilateral institutions and others to ensure access to all countries regardless of their income level.

 

“Boehringer Ingelheim believes that a solution to this pandemic can only be found through broad collaboration across companies, institutions and countries” states Hubertus von Baumbach, Chairman of the Board of Managing Directors. “We are contributing to several initiatives and on many levels to bring together the best of science and knowledge to defeat COVID-19. Since January, a highly committed group of people at Boehringer Ingelheim, with a very broad skillset, has passionately contributed their know-how. They seek solutions to end the pandemic, with a focus on a range of treatment options. We support the COVID-19 global access communiqué to bring new, effective products to all patients who need them around the world. We are calling on the private and public sector to join us in this commitment.”